AntineoplasticsLack of efficacy, treatment failure and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1926卷 / 1期

关键词：

D O I：

10.1007/s40278-022-24341-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：63 / 63

相关论文

共 50 条

[41] MethotrexateTreatment failure and off-label use: case report
[J]. Reactions Weekly, 2022, 1892 (1) : 148 - 148
[42] IdebenoneLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1929 (1) : 335 - 335
[43] LetermovirLack of efficacy and off-label use : case report
[J]. Reactions Weekly, 2024, 2019 (1) : 242 - 242
[44] FavipiravirLack of efficacy and off-label treatment: case report
[J]. Reactions Weekly, 2023, 1981 (1) : 179 - 179
[45] AntineoplasticsLack of efficacy and various toxicities following off-label use: 26 case reports
[J]. Reactions Weekly, 2023, 1950 (1) : 47 - 47
[46] Multiple drugsVarious toxicities, treatment failure and off-label use: case report
[J]. Reactions Weekly, 2020, 1834 (1) : 199 - 199
[47] Antibacterials/itraconazoleVarious toxicities, treatment failure and off-label use: case report
[J]. Reactions Weekly, 2022, 1908 (1) : 54 - 54
[48] Multiple drugsVarious toxicities, treatment failure and off-label use: case report
[J]. Reactions Weekly, 2021, 1854 (1) : 268 - 268
[49] AntineoplasticsLack of efficacy, off-label use, pneumonia and myocardial enzyme elevation
[J]. Reactions Weekly, 2024, 2013 (1) : 50 - 50
[50] Multiple drugsLack of efficacy, acute liver failure and off-label use: case report
[J]. Reactions Weekly, 2023, 1977 (1) : 199 - 199

← 1 2 3 4 5 →